Virax Biolabs Group Limited (VRAX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-05-15
11:14 am
Purchase		2026-03-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Armistice Capital, LLC40,010
4.990%		7,054increase
(+21.40%)		Filing
History
2026-02-17
9:42 pm
Purchase		2025-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Armistice Capital, LLC32,956
9.990%		23,834increase
(+261.28%)		Filing
History
2025-10-29
5:16 pm
Purchase		2025-03-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Foster James Alexander Cunliffe14,743
8.300%		1,945increase
(+15.20%)		Filing
History
2025-10-29
5:16 pm
Purchase		2024-09-3013GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Foster James Alexander Cunliffe12,798
7.300%		1,279increase
(+11.10%)		Filing
History
2025-10-29
5:11 pm
Unchanged		2023-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Foster James Alexander Cunliffe11,519
12.900%		0
(Unchanged)		Filing
History
2025-10-29
5:09 pm
Purchase		2022-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Foster James Alexander Cunliffe11,519
24.900%		11,519increase
(New Position)		Filing
History
2024-11-14
4:46 pm
Sale		2024-09-3013GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Armistice Capital, LLC9,122
4.990%		-84decrease
(-0.91%)		Filing
History
2024-02-14
3:56 pm
Purchase		2023-12-3113GVIRAX BIOLABS GROUP LTD SHS NE
VRAX		Armistice Capital, LLC9,206
9.990%		9,206increase
(New Position)		Filing
History